This site is intended for U.S. healthcare professionals.
Prevnar 20® contains serotypes that account for the majority of cases of IPD in adults in
There are currently no studies comparing the efficacy of Prevnar 20 to a 15-valent
pneumococcal conjugate vaccine.
Prevnar 20 contains serotypes associated with many cases of community-acquired pneumonia.2,3
With the most serotypes in a pneumococcal conjugate vaccine, you can help protect your eligible adult patients.2
To report an adverse event, please call 1-800-438-1985
Pfizer for Professionals 1-800-505-4426
This site is intended only for U.S. healthcare professionals. The products discussed in this site may have different product labeling in different countries. The information provided is for educational purposes only.
© 2023 Pfizer Inc. All rights reserved.